# Safety of Adipose-Derived Stem Cell Stromal Vascular Fraction

> **NCT02590042** · PHASE1 · UNKNOWN · sponsor: **AdiSave Inc.** · enrollment: 10 (estimated)

## Conditions studied

- Abnormally Healing Wounds
- Scars
- Soft Tissue Defects

## Interventions

- **BIOLOGICAL:** ADSC-SVF-002

## Key facts

- **NCT ID:** NCT02590042
- **Lead sponsor:** AdiSave Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-10
- **Primary completion:** 2020-10
- **Final completion:** 2021-01
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2017-07-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02590042

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02590042, "Safety of Adipose-Derived Stem Cell Stromal Vascular Fraction". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02590042. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*